Publication Information

{'id': 'https://openalex.org/W2252065383', 'doi': 'https://doi.org/10.1586/14737140.2016.1131612', 'title': 'Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib', 'display_name': 'Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib', 'publication_year': 2015, 'publication_date': '2015-12-12', 'ids': {'openalex': 'https://openalex.org/W2252065383', 'doi': 'https://doi.org/10.1586/14737140.2016.1131612', 'mag': '2252065383', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26654422'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1586/14737140.2016.1131612', 'pdf_url': 'https://www.tandfonline.com/doi/pdf/10.1586/14737140.2016.1131612?needAccess=true', 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://www.tandfonline.com/doi/pdf/10.1586/14737140.2016.1131612?needAccess=true', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052104368', 'display_name': 'Ittai B. Muller', 'orcid': 'https://orcid.org/0000-0003-3211-2982'}, 'institutions': [{'id': 'https://openalex.org/I911458345', 'display_name': 'Amsterdam UMC Location VUmc', 'ror': 'https://ror.org/00q6h8f30', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210151833', 'https://openalex.org/I911458345']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Ittai B Muller', 'raw_affiliation_strings': ['Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I911458345']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057162992', 'display_name': 'Adrianus J. de Langen', 'orcid': 'https://orcid.org/0000-0001-7343-633X'}, 'institutions': [{'id': 'https://openalex.org/I911458345', 'display_name': 'Amsterdam UMC Location VUmc', 'ror': 'https://ror.org/00q6h8f30', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210151833', 'https://openalex.org/I911458345']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Adrianus J De Langen', 'raw_affiliation_strings': ['Department of Medical Pulmonology, VU University Medical Center, Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Pulmonology, VU University Medical Center, Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I911458345']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020883449', 'display_name': 'Richard J. Honeywell', 'orcid': 'https://orcid.org/0000-0001-9415-5959'}, 'institutions': [{'id': 'https://openalex.org/I911458345', 'display_name': 'Amsterdam UMC Location VUmc', 'ror': 'https://ror.org/00q6h8f30', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210151833', 'https://openalex.org/I911458345']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Richard J Honeywell', 'raw_affiliation_strings': ['Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I911458345']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041229832', 'display_name': 'Elisa Giovannetti', 'orcid': 'https://orcid.org/0000-0002-7565-7504'}, 'institutions': [{'id': 'https://openalex.org/I911458345', 'display_name': 'Amsterdam UMC Location VUmc', 'ror': 'https://ror.org/00q6h8f30', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210151833', 'https://openalex.org/I911458345']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'Elisa Giovannetti', 'raw_affiliation_strings': ['Cancer Pharmacology Lab, AIRC Start-Up Unit, DIPINT, Pisa, Italy', 'Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I911458345']}, {'raw_affiliation_string': 'Cancer Pharmacology Lab, AIRC Start-Up Unit, DIPINT, Pisa, Italy', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5035296183', 'display_name': 'Godefridus J. Peters', 'orcid': 'https://orcid.org/0000-0002-5447-2877'}, 'institutions': [{'id': 'https://openalex.org/I911458345', 'display_name': 'Amsterdam UMC Location VUmc', 'ror': 'https://ror.org/00q6h8f30', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210151833', 'https://openalex.org/I911458345']}], 'countries': ['NL'], 'is_corresponding': True, 'raw_author_name': 'Godefridus J Peters', 'raw_affiliation_strings': ['Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands', 'institution_ids': ['https://openalex.org/I911458345']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5035296183'], 'corresponding_institution_ids': ['https://openalex.org/I911458345'], 'apc_list': None, 'apc_paid': None, 'fwci': 1.548, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 38, 'citation_normalized_percentile': {'value': 0.999594, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '16', 'issue': '2', 'first_page': '147', 'last_page': '157'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Small Cell Lung Cancer', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'DNA Topoisomerases: Structure, Function, and Inhibition', 'score': 0.9904, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ceritinib', 'display_name': 'Ceritinib', 'score': 0.98563576}, {'id': 'https://openalex.org/keywords/alectinib', 'display_name': 'Alectinib', 'score': 0.9453548}, {'id': 'https://openalex.org/keywords/alk-inhibitor', 'display_name': 'ALK inhibitor', 'score': 0.7948718}, {'id': 'https://openalex.org/keywords/alk-inhibitors', 'display_name': 'ALK Inhibitors', 'score': 0.537598}, {'id': 'https://openalex.org/keywords/osimertinib', 'display_name': 'Osimertinib', 'score': 0.5075232}], 'concepts': [{'id': 'https://openalex.org/C2779422266', 'wikidata': 'https://www.wikidata.org/wiki/Q5186964', 'display_name': 'Crizotinib', 'level': 4, 'score': 0.9963519}, {'id': 'https://openalex.org/C2779750558', 'wikidata': 'https://www.wikidata.org/wiki/Q21011233', 'display_name': 'Ceritinib', 'level': 5, 'score': 0.98563576}, {'id': 'https://openalex.org/C2779220645', 'wikidata': 'https://www.wikidata.org/wiki/Q21099132', 'display_name': 'Alectinib', 'level': 5, 'score': 0.9453548}, {'id': 'https://openalex.org/C117643217', 'wikidata': 'https://www.wikidata.org/wiki/Q17824987', 'display_name': 'Anaplastic lymphoma kinase', 'level': 4, 'score': 0.8139117}, {'id': 'https://openalex.org/C2778347629', 'wikidata': 'https://www.wikidata.org/wiki/Q4652380', 'display_name': 'ALK inhibitor', 'level': 5, 'score': 0.7948718}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.68308246}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.6260713}, {'id': 'https://openalex.org/C2777626846', 'wikidata': 'https://www.wikidata.org/wiki/Q21506464', 'display_name': 'Osimertinib', 'level': 5, 'score': 0.5075232}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5032813}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3206393}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2847271}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.22301742}, {'id': 'https://openalex.org/C2775999482', 'wikidata': 'https://www.wikidata.org/wiki/Q18031208', 'display_name': 'ROS1', 'level': 4, 'score': 0.19480771}, {'id': 'https://openalex.org/C2781182431', 'wikidata': 'https://www.wikidata.org/wiki/Q356033', 'display_name': 'Adenocarcinoma', 'level': 3, 'score': 0.13143972}, {'id': 'https://openalex.org/C2776232967', 'wikidata': 'https://www.wikidata.org/wiki/Q6743514', 'display_name': 'Malignant pleural effusion', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000077548', 'descriptor_name': 'Anaplastic Lymphoma Kinase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077547', 'descriptor_name': 'Crizotinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011720', 'descriptor_name': 'Pyrazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013450', 'descriptor_name': 'Sulfones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013450', 'descriptor_name': 'Sulfones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013450', 'descriptor_name': 'Sulfones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1586/14737140.2016.1131612', 'pdf_url': 'https://www.tandfonline.com/doi/pdf/10.1586/14737140.2016.1131612?needAccess=true', 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26654422', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1586/14737140.2016.1131612', 'pdf_url': 'https://www.tandfonline.com/doi/pdf/10.1586/14737140.2016.1131612?needAccess=true', 'source': {'id': 'https://openalex.org/S93370067', 'display_name': 'Expert Review of Anticancer Therapy', 'issn_l': '1473-7140', 'issn': ['1473-7140', '1744-8328'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.85, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 53, 'referenced_works': ['https://openalex.org/W1505421350', 'https://openalex.org/W1531539580', 'https://openalex.org/W1756205400', 'https://openalex.org/W1788779879', 'https://openalex.org/W1870864846', 'https://openalex.org/W1871221741', 'https://openalex.org/W1971427051', 'https://openalex.org/W1972760716', 'https://openalex.org/W1974903221', 'https://openalex.org/W1990013637', 'https://openalex.org/W1991939027', 'https://openalex.org/W1997476230', 'https://openalex.org/W1997601288', 'https://openalex.org/W2002937040', 'https://openalex.org/W2010619956', 'https://openalex.org/W2014639631', 'https://openalex.org/W2015137322', 'https://openalex.org/W2015431189', 'https://openalex.org/W2022670843', 'https://openalex.org/W2032974400', 'https://openalex.org/W2044936103', 'https://openalex.org/W2052016211', 'https://openalex.org/W2052546787', 'https://openalex.org/W2060887105', 'https://openalex.org/W2063725919', 'https://openalex.org/W2066417528', 'https://openalex.org/W2068018698', 'https://openalex.org/W2072744949', 'https://openalex.org/W2080992857', 'https://openalex.org/W2084687092', 'https://openalex.org/W2097757428', 'https://openalex.org/W2099530756', 'https://openalex.org/W2100235578', 'https://openalex.org/W2103600998', 'https://openalex.org/W2104830962', 'https://openalex.org/W2106915761', 'https://openalex.org/W2113327188', 'https://openalex.org/W2123394258', 'https://openalex.org/W2125735484', 'https://openalex.org/W2136549983', 'https://openalex.org/W2144539352', 'https://openalex.org/W2147038864', 'https://openalex.org/W2148613928', 'https://openalex.org/W2151116840', 'https://openalex.org/W2163798887', 'https://openalex.org/W2168106545', 'https://openalex.org/W2170552969', 'https://openalex.org/W2171691367', 'https://openalex.org/W2172010139', 'https://openalex.org/W2224395257', 'https://openalex.org/W2472128711', 'https://openalex.org/W2525528564', 'https://openalex.org/W2596888329'], 'related_works': ['https://openalex.org/W2825193760', 'https://openalex.org/W2809930967', 'https://openalex.org/W2792034737', 'https://openalex.org/W2772410896', 'https://openalex.org/W2533300620', 'https://openalex.org/W2531312194', 'https://openalex.org/W2337452654', 'https://openalex.org/W2319183095', 'https://openalex.org/W2252065383', 'https://openalex.org/W2148613928'], 'abstract_inverted_index': {'In': [0], 'up': [1], 'to': [2, 31, 62, 75, 123, 127], '5%': [3], 'of': [4, 48, 54, 109], 'non-small': [5], 'cell': [6], 'lung': [7], 'cancer': [8], '(NSCLC)': [9], 'patients,': [10], 'the': [11, 19, 40, 55, 116], 'EML4-ALK': [12], 'translocation': [13], 'drives': [14], 'tumor': [15], 'progression.': [16], 'Treatment': [17], 'with': [18, 69], 'ALK': [20, 43, 70, 88, 104], 'inhibitor': [21, 44], 'crizotinib': [22, 32, 78], 'is': [23, 39, 112], 'more': [24, 73], 'effective': [25], 'than': [26, 77], 'standard': [27], 'chemotherapy.': [28], 'However,': [29], 'resistance': [30, 61, 125], 'occurs': [33], 'after': [34], 'approximately': [35], '8': [36], 'months.': [37], 'Ceritinib': [38, 51], 'first': [41], 'second-generation': [42, 87], 'approved': [45], 'for': [46, 114], 'treatment': [47, 118], 'crizotinib-resistant': [49, 103, 110], 'NSCLC.': [50], 'inhibits': [52], 'two': [53], 'most': [56], 'common': [57], 'ALK-mutants': [58], 'that': [59], 'confer': [60], 'crizotinib:': [63], 'L1196': [64], 'M': [65], 'and': [66, 94, 126], 'G1269A.': [67], 'Cells': [68], 'expression': [71], 'are': [72, 96], 'sensitive': [74], 'ceritinib': [76], '(IC50': [79], '25': [80], 'nM': [81], 'vs.': [82], '150': [83], 'nM,': [84], 'respectively).': [85], 'Alternative': [86], 'inhibitors': [89], 'such': [90], 'as': [91], 'Alectinib,': [92], 'Brigatinib': [93], 'PF-06463922': [95], 'currently': [97], 'in': [98, 120], 'development,': [99], 'each': [100], 'affecting': [101], 'different': [102], 'target': [105], 'mutations.': [106], 'Genetic': [107], 'identification': [108], 'mutants': [111], 'essential': [113], 'selecting': [115], 'optimal': [117], 'strategy': [119], 'NSCLC': [121], 'patients': [122], 'overcome': [124], 'increase': [128], 'progression-free': [129], 'survival.': [130]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2252065383', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 7}, {'year': 2018, 'cited_by_count': 9}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 4}], 'updated_date': '2024-09-24T08:11:24.662754', 'created_date': '2016-06-24'}